// App-Quantinova.ai

1160 : Real-World Study of Dabigatran Etexilate for Thromboprophylaxis in Over 5000 Hip or Knee Replacement Patients: Favourable Safety Profile in Subgroups with Different BMI, Renal Function and Age

Researchers

Presenter

  • Simon Frostick

Principal Investigators

  • Charles Marc Samama

  • Martin Feuring

  • Co. KG

  • Eva Kleine

  • Martina Brueckmann

  • Andreas Clemens

Medical Centers

  • Ingelheim, Germany

  • Royal Liverpool University Hospital, Liverpool, United Kingdom

  • Department of Anaesthesia and Intensive Care Medicine, Cochin University Hospital, Paris, France

Locations

  • France

  • Germany

  • United Kingdom

Companies

  • Boehringer Ingelheim

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

  • Renal insufficiency

Biomarkers

  • Creatinine

  • Transketolase Like 1

  • Body mass index

Drug/Treatment

  • Pradax

  • Amiodarone Hydrochloride

  • Enoxaparin

  • Enoxaparin sodium

  • Calan

  • Quinidex Extentabs

Outcome

  • N/A

Study Design

  • single arm

  • observational

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved